<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>There is strong evidence that vascular risk factors play a role in the development of <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD) or vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (vaD) </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="37" ids="16236,44730">Ethanol</z:chebi> (<z:chebi fb="0" ids="16236">EtOH</z:chebi>) and cholesterol are such vascular risk factors, and we recently showed that <z:hpo ids='HP_0003124'>hypercholesterolemia</z:hpo> causes pathologies similar to AD [Ullrich et al </plain></SENT>
<SENT sid="2" pm="."><plain>(2010) Mol Cell Neurosci 45, 408-417] </plain></SENT>
<SENT sid="3" pm="."><plain>The aim of this study was to investigate the effects of long-term (12 months) <z:chebi fb="0" ids="16236">EtOH</z:chebi> treatment (20% v/v in drinking water) alone or long-term 5% cholesterol diet alone or a combination (mix) in adult Sprague-Dawley rats </plain></SENT>
<SENT sid="4" pm="."><plain>Long-term <z:chebi fb="0" ids="16236">EtOH</z:chebi> treatment (plasma <z:chebi fb="0" ids="16236">EtOH</z:chebi> levels 58Â±23 mg/dl) caused significant impairment of spatial memory, reduced the number of <z:chebi fb="3" ids="15354">choline</z:chebi> acetyltransferase- and p75 neurotrophin receptor-positive nucleus basalis of Meynert neurons, decreased cortical <z:chebi fb="9" ids="15355">acetylcholine</z:chebi>, elevated cortical monocyte chemoattractant protein-1 and tissue-type plasminogen activator, enhanced microglia, and markedly induced anti-rat immunoglobulin G-positive blood-brain barrier leakage </plain></SENT>
<SENT sid="5" pm="."><plain>The effect of long-term <z:hpo ids='HP_0003124'>hypercholesterolemia</z:hpo> was similar </plain></SENT>
<SENT sid="6" pm="."><plain>Combined long-term treatment of rats with 20% <z:chebi fb="0" ids="16236">EtOH</z:chebi> and 5% cholesterol (mix) did not potentiate treatment with <z:chebi fb="0" ids="16236">EtOH</z:chebi> alone, but instead counteracted some of the <z:chebi fb="0" ids="16236">EtOH</z:chebi>-associated effects </plain></SENT>
<SENT sid="7" pm="."><plain>In conclusion, our data show that vascular risk factors <z:chebi fb="0" ids="16236">EtOH</z:chebi> and cholesterol play a role in <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> and possibly vaD </plain></SENT>
</text></document>